as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.09%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
4.93%
Downside
27.77%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$116.2B
EPS (TTM)
4.6154
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
2.67%
PE Ratio (TTM)
15.83
Industry PE ratio
16.65525641025641
P/B Ratio
15.8306
PEG Ratio
0.7367
EBITDA
12.1B
Revenue (TTM)
45.7B
Profit Margin
19.95%
Return On Equity TTM
9.00%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Today (15.83x)
September 13, 2025
Industry (16.66x)
September 13, 2025
Highest (15.05x)
September 30, 2020
Today’s Price to Earnings Ratio: 15.83x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $116.2B | -8.15% | 15.83 | 19.95% | |
BUY | $677.2B | 410.09% | 49.44 | 25.91% | |
BUY | $385.7B | 143.41% | 103.97 | 6.45% | |
BUY | $428.8B | 20.49% | 19.04 | 25.00% | |
BUY | $244.6B | 63.43% | 13.89 | 35.61% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹87,495
Returns
Returns from Sanofi Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $61.61
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
23.63%UPSIDE
Target Price
$61.61
Current Price
$47.05
Analyzed by
31 Analysts
Target
$61.61
Sanofi target price $61.61, a slight upside of 23.63% compared to current price of $47.05. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has grown by 98.80% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:98.80%Â versus previous 30 day period
Search interest for Sanofi Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:31%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 September
Thu, 11:46 AM
-Sanofi receives FDA fast track designation for SAR402663 gene therapy targeting neovascular AMD, expediting development and review process.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Sanofi has shown positive revenue trends over the last three quarters. Its revenue increased from $7.63 billion to $10.73 billion, reflecting an average growth of 14.6% per quarter.
Profit Spike
Sanofi has shown strong performance in its net profit over the last three quarters. The net profit increased from $499.0 million to $3.94 billion, demonstrating a remarkable average growth of 62.9% per quarter.
Against Peers
In the last 1 year, Abbvie Inc has given 12.4% return, outperforming this stock by 30.1%
Against Peers
In the last 3 years, Eli Lilly And Company has given 57.6% return, outperforming this stock by 41.5%
Price Dip
In the last 6 months, SNY stock has moved down by -18.5%
Organisation | Sanofi |
Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
Industry | Health Technology |
CEO | Mr. Paul Hudson |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Mr. Felix Lauscher | Head of IR North America & Asia |
Mr. Paul Hudson | CEO & Director |
Mr. François-Xavier Roger | Executive VP & CFO |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Mr. Thomas Kudsk Larsen | Head of Investor Relations |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Mr. Olivier Charmeil | Executive Vice President of General Medicines |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Sanofi share price today is $47.05 as on at the close of the market. Sanofi share today touched a day high of $47.67 and a low of $47.01.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.73 on . Sanofi stock price today i.e. is closed at $47.05,which is 21.73% down from its 52 week high and 5.19% up from its 52 week low.
Sanofi market capitalisation is $0.12T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $47.05 as on September 13, 2025 at 1:29 am IST, you will get 0.2125 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -8.15% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?